DIFLORASONE DIACETATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Diflorasone Diacetate, and what generic alternatives are available?
Diflorasone Diacetate is a drug marketed by Ani Pharms, Avondale Pharms, Sun Pharma Canada, Rising, Sciegen Pharms, and The J Molner. and is included in eight NDAs.
The generic ingredient in DIFLORASONE DIACETATE is diflorasone diacetate. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the diflorasone diacetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diflorasone Diacetate
A generic version of DIFLORASONE DIACETATE was approved as diflorasone diacetate by AVONDALE PHARMS on April 27th, 1999.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DIFLORASONE DIACETATE?
- What are the global sales for DIFLORASONE DIACETATE?
- What is Average Wholesale Price for DIFLORASONE DIACETATE?
Summary for DIFLORASONE DIACETATE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Patent Applications: | 8,455 |
| Drug Prices: | Drug price information for DIFLORASONE DIACETATE |
| DailyMed Link: | DIFLORASONE DIACETATE at DailyMed |
Pharmacology for DIFLORASONE DIACETATE
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for DIFLORASONE DIACETATE
US Patents and Regulatory Information for DIFLORASONE DIACETATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | DIFLORASONE DIACETATE | diflorasone diacetate | CREAM;TOPICAL | 076263-001 | Dec 20, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharma Canada | DIFLORASONE DIACETATE | diflorasone diacetate | OINTMENT;TOPICAL | 075331-001 | May 14, 1999 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Avondale Pharms | DIFLORASONE DIACETATE | diflorasone diacetate | OINTMENT;TOPICAL | 075374-001 | Apr 27, 1999 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| The J Molner | DIFLORASONE DIACETATE | diflorasone diacetate | OINTMENT;TOPICAL | 210753-001 | Jun 12, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
